Voyageur Pharmaceuticals Ltd Total Liabilities
Voyageur Pharmaceuticals Ltd total liabilities. Based on the latest financial reports, Voyageur Pharmaceuticals Ltd (VM) has total liabilities worth CA$1.85 Million CAD (≈ $1.34 Million USD) as of November 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. See Voyageur Pharmaceuticals Ltd defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Total Liabilities of Voyageur Pharmaceuticals Ltd (2011–2025)
Total liabilities of Voyageur Pharmaceuticals Ltd from 2011 to 2025. This chart illustrates how Voyageur Pharmaceuticals Ltd's total liabilities have evolved over time, based on quarterly financial data. Check Voyageur Pharmaceuticals Ltd asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Voyageur Pharmaceuticals Ltd Competitors by Total Liabilities
The table below lists competitors of Voyageur Pharmaceuticals Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
PCCS Group Bhd
KLSE:6068
|
Malaysia | RM162.58 Million |
|
Black Iron Inc.
TO:BKI
|
Canada | CA$4.28 Million |
|
Macompta Fr Sa
PA:MLMCA
|
France | €1.38 Million |
|
Trinity Watthana Public Company Limited
BK:TNITY
|
Thailand | ฿2.87 Billion |
|
Lighting and Equipment Public Company Limited
BK:L&E
|
Thailand | ฿1.78 Billion |
|
111 Inc
NASDAQ:YI
|
USA | $253.22 Million |
|
Yorbeau Resources Inc
TO:YRB
|
Canada | CA$276.88K |
|
Cordoba Minerals Corp
V:CDB
|
Canada | CA$7.61 Million |
Liability Composition Analysis (2011–2025)
This chart breaks down Voyageur Pharmaceuticals Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see balance sheet size of Voyageur Pharmaceuticals Ltd.
Liquidity & Leverage Metrics
Voyageur Pharmaceuticals Ltd Total Liabilities Ratios Explained
Voyageur Pharmaceuticals Ltd total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.33 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.48 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.60 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Voyageur Pharmaceuticals Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Voyageur Pharmaceuticals Ltd (2011–2025)
The table below shows the annual total liabilities of Voyageur Pharmaceuticals Ltd from 2011 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-11-30 | CA$1.85 Million ≈ $1.34 Million |
-13.77% |
| 2024-11-30 | CA$2.15 Million ≈ $1.55 Million |
+195.16% |
| 2023-11-30 | CA$727.88K ≈ $526.54K |
+15.38% |
| 2022-11-30 | CA$630.83K ≈ $456.33K |
-4.51% |
| 2021-11-30 | CA$660.64K ≈ $477.89K |
-31.81% |
| 2020-11-30 | CA$968.85K ≈ $700.85K |
+13.62% |
| 2019-11-30 | CA$852.69K ≈ $616.82K |
+13.57% |
| 2018-11-30 | CA$750.79K ≈ $543.11K |
-21.72% |
| 2017-11-30 | CA$959.12K ≈ $693.81K |
+2368.08% |
| 2016-11-30 | CA$38.86K ≈ $28.11K |
+318.67% |
| 2015-11-30 | CA$9.28K ≈ $6.71K |
-88.17% |
| 2014-11-30 | CA$78.45K ≈ $56.75K |
+814.22% |
| 2013-11-30 | CA$8.58K ≈ $6.21K |
-63.44% |
| 2012-11-30 | CA$23.47K ≈ $16.98K |
+10.68% |
| 2011-11-30 | CA$21.21K ≈ $15.34K |
-- |
About Voyageur Pharmaceuticals Ltd
Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in acquiring, exploring, and developing raw materials for pharmaceutical products in the United States of America, the province of British Columbia, Canada, and the state of Utah. It develops barium and iodine-based APIs. The company offers Smooth HD, Smooth X, Smooth LD, Vision HD, Vision LD, V-Gas, and other products. The co… Read more